| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.0096 | 0.8 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.04 | 0.8 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.0075 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |